Zoetis Inc. (ZTS)

USD 167.01

(-2.21%)

Total Debt Summary of Zoetis Inc.

  • Zoetis Inc.'s latest annual total debt in 2023 was 6.8 Billion USD , down -15.91% from previous year.
  • Zoetis Inc.'s latest quarterly total debt in 2024 Q3 was 6.75 Billion USD , up 0.16% from previous quarter.
  • Zoetis Inc. reported annual total debt of 8.09 Billion USD in 2022, up 19.98% from previous year.
  • Zoetis Inc. reported annual total debt of 6.74 Billion USD in 2021, down -8.41% from previous year.
  • Zoetis Inc. reported quarterly total debt of 6.75 Billion USD for 2024 Q3, up 0.16% from previous quarter.
  • Zoetis Inc. reported quarterly total debt of 6.74 Billion USD for 2024 Q2, down -0.38% from previous quarter.

Annual Total Debt Chart of Zoetis Inc. (2023 - 2010)

Historical Annual Total Debt of Zoetis Inc. (2023 - 2010)

Year Total Debt Total Debt Growth
2023 6.8 Billion USD -15.91%
2022 8.09 Billion USD 19.98%
2021 6.74 Billion USD -8.41%
2020 7.36 Billion USD 11.36%
2019 6.61 Billion USD 2.46%
2018 6.45 Billion USD 30.26%
2017 4.95 Billion USD 10.85%
2016 4.46 Billion USD -8.22%
2015 4.86 Billion USD 33.37%
2014 3.65 Billion USD -0.19%
2013 3.65 Billion USD 528.35%
2012 582 Million USD 1.22%
2011 575 Million USD -19.13%
2010 711 Million USD 0.0%

Peer Total Debt Comparison of Zoetis Inc.

Name Total Debt Total Debt Difference
Amneal Pharmaceuticals, Inc. 2.75 Billion USD -147.335%
Bausch Health Companies Inc. 22.38 Billion USD 69.613%
Catalent, Inc. 4.98 Billion USD -36.387%
Emergent BioSolutions Inc. 877.5 Million USD -675.271%
Elanco Animal Health Incorporated 5.77 Billion USD -17.821%
Perrigo Company plc 4.07 Billion USD -67.01%
Teva Pharmaceutical Industries Limited 20.15 Billion USD 66.243%